Testing effectiveness (Phase 2)Ended earlyNCT04096560What this trial is testingTAK-994 in Adults With Type 1 and Type 2 NarcolepsyWho this might be right forNarcolepsy Type 1 (NT1)Narcolepsy Type 2 (NT2) Takeda 97
Large-scale testing (Phase 3)Looking for participantsNCT06767683What this trial is testingA Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic HypersomniaWho this might be right forNarcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia Alkermes, Inc. 256
Testing effectiveness (Phase 2)Looking for participantsNCT07096674What this trial is testingA Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic HypersomniaWho this might be right forNarcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia Centessa Pharmaceuticals (UK) Limited 90
Large-scale testing (Phase 3)Not Yet RecruitingNCT07502443What this trial is testingEvaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2Who this might be right forNarcolepsy Type 2 Alkermes, Inc. 176
Testing effectiveness (Phase 2)Looking for participantsNCT06952699What this trial is testingTAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)Who this might be right forNarcolepsy Type 2 Takeda 88
Testing effectiveness (Phase 2)Study completedNCT06555783What this trial is testingEvaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2Who this might be right forNarcolepsy Type 2 Alkermes, Inc. 93
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07493265What this trial is testingEvaluate the Efficacy and Safety of E2086 in Adults With NarcolepsyWho this might be right forNarcolepsy Eisai Inc. 64
Not applicableLooking for participantsNCT07006233What this trial is testingA Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic HypersomniaWho this might be right forIdiopathic HypersomniaNarcolepsy Type 1 (NT 1)Narcolepsy Type 2 (NT2) University of Sydney 30